Hottest Stocks
(Over $10)
Hottest Stocks
($2-$10)
Biggest Losers
(Over $10)
Biggest Losers
($2-$10)
Hottest
Industries
Hottest
Sectors
EPS / Sales
Surprises
 
Enter Ticker Symbol:   Ticker Lookup
 

Enter any portion of the company’s name to find its corresponding ticker symbol:
Search for :   

Zacks Company Profile for NanoString Technologies, Inc. (NSTG : NSDQ)
 
 • Company Description   
NanoString Technologies, Inc. is engaged in the development, manufacture and sale of life science tools. It provides nCounter Analysis System which supports research and development of clinical applications from basic discovery to the development of future molecular diagnostic tests on a single platform. The company also offers nSolver Analysis software, gene expression panels, miRNA expression assay kits, cancer copy number variation panels, nCounter leukemia fusion gene expression assay kits and human karyotype panels, custom CodeSets and master kits that are ancillary reagents, cartridges, tips and reagent plates to setup and process samples in its instruments. It markets its systems and related consumables to researchers in academic, government and biopharmaceutical laboratories primarily in North America, Europe, the Middle East and the Asia Pacific. NanoString Technologies, Inc. is headquartered in Seattle, Washington.

Number of Employees: 766

 
 • Price / Volume Information   
Yesterday's Closing Price: $16.01 Daily Weekly Monthly
20 Day Moving Average: 1,055,550 shares
Shares Outstanding: 46.42 (millions)
Market Capitalization: $743.12 (millions)
Beta: 1.98
52 Week High: $70.40
52 Week Low: $13.52
Short Interest Ratio:
  % Price Change % Price Change Relative to S&P 500
4 Week -18.94% -8.71%
12 Week -53.13% -48.48%
Year To Date -62.09% -53.88%
 
 • Address & Contact Information
Street Address Phone / Fax Email Address Web URL
530 FAIRVIEW AVENUE NORTH SUITE 2000
-
SEATTLE,WA 98109
USA
ph: 206-378-6266
fax: 206-378-6288
investorrelations@nanostring.com http://www.nanostring.com
 
 • General Corporate Information   
Officers
R. Bradley Gray - President; Chief Executive Officer
William D. Young - Chairman of the Board of Directors
K. Thomas Bailey - Chief Financial Officer
Elisha W. Finney - Director
Janet George - Director

Peer Information
NanoString Technologies, Inc. (BJCT)
NanoString Technologies, Inc. (CADMQ)
NanoString Technologies, Inc. (APNO)
NanoString Technologies, Inc. (UPDC)
NanoString Technologies, Inc. (IMTIQ)
NanoString Technologies, Inc. (CYGN)
Industry / Sector / Ticker Info
Analyst Coverage: No
Industry Group: MED PRODUCTS
Sector: Medical
CUSIP: 63009R109
SIC: 2836
Fiscal Year
Fiscal Year End: December
Last Reported Quarter: 03/01/22
Next Expected EPS Date: 08/03/22
Share - Related Items
Shares Outstanding: 46.42
Most Recent Split Date: (:1)
Beta: 1.98
Market Capitalization: $743.12 (millions)
 
 
 • EPS Information     • Dividend Information
Analyst Coverage: No Dividend Yield: 0.00%
Current Fiscal Quarter EPS Consensus Estimate: $-0.67 Indicated Annual Dividend: $0.00
Current Fiscal Year EPS Consensus Estimate: $-2.64 Payout Ratio:
Number of Estimates in the Fiscal Year Consensus: 3.00 Change In Payout Ratio:
Estmated Long-Term EPS Growth Rate: % Last Dividend Paid: NA - $0.00
Next EPS Report Date: 08/03/22  
 

 • Fundamental Ratios
P/E
Current FY Estimate: -
Trailing 12 Months: -
PEG Ratio: -
Price Ratios
Price/Book: 5.11
Price/Cash Flow: -
Price / Sales: 5.14
EPS Growth
vs. Year Ago Period: -38.71%
vs. Previous Quarter: -34.38%
Sales Growth
vs. Year Ago Period: -1.70%
vs. Previous Quarter: -26.79%
ROE
03/31/22 - -68.57
12/31/21 - -55.40
09/30/21 - -45.31
ROA
03/31/22 - -26.32
12/31/21 - -22.98
09/30/21 - -21.05
Current Ratio
03/31/22 - 7.81
12/31/21 - 8.20
09/30/21 - 10.03
Quick Ratio
03/31/22 - 7.11
12/31/21 - 7.60
09/30/21 - 9.33
Operating Margin
03/31/22 - -87.89
12/31/21 - -79.44
09/30/21 - -78.48
Net Margin
03/31/22 - -87.89
12/31/21 - -79.44
09/30/21 - -78.48
Pre-Tax Margin
03/31/22 - -87.76
12/31/21 - -79.32
09/30/21 - -78.38
Book Value
03/31/22 - 3.13
12/31/21 - 3.88
09/30/21 - 4.37
Inventory Turnover
03/31/22 - 2.14
12/31/21 - 2.36
09/30/21 - 2.42
Debt-to-Equity
03/31/22 - 1.55
12/31/21 - 1.27
09/30/21 - 1.13
Debt-to-Capital
03/31/22 - 60.81
12/31/21 - 55.99
09/30/21 - 53.03
 

Powered by Zacks Investment Research ©